Study Identifies Patients with Obesity Most Likely to Benefit From GLP-1-Based Treatment
ROCHESTER, Minn., July 18: Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype…
